Form 8-K - Current report:
SEC Accession No. 0001104659-21-054506
Filing Date
2021-04-23
Accepted
2021-04-23 16:45:08
Documents
12
Period of Report
2021-04-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2113826d1_8k.htm   iXBRL 8-K 23902
  Complete submission text file 0001104659-21-054506.txt   196936

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rytm-20210423.xsd EX-101.SCH 3187
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20210423_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20210423_pre.xml EX-101.PRE 22711
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2113826d1_8k_htm.xml XML 3614
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 21850434
SIC: 2834 Pharmaceutical Preparations